As drug costs and medicolegal scrutiny increase, the future of many drugs appears murky, said Stephen E. Wolverton, M.D., at the 70th annual meeting of the American Academy of Dermatology.
The product development pipeline will deliver game-changing injectable fat treatments in the very near future, according to one dermatologist.
Sentinel lymph node (SLN) status represents the most important prognostic factor for disease-specific survival in primary cutaneous melanomas, said Christopher K. Bichakjian, M.D., at the 70th annual meeting of the American Academy of Dermatology. However, he says, its impact on overall survival remains unclear.
"A new microwave-based device is achieving long-lasting results in treating hyperhidrosis, said Suzanne L. Kilmer, M.D., at this year's MauiDerm: Advances in Cosmetic and Medical Dermatology. Approved for primary axillary hyperhidrosis in January 2011, the miraDry System (Miramar Labs) essentially kills targeted sweat glands with microwave energy."
Treating dermatologic issues associated with pregnancy often requires individualized treatments combining various agents, an expert says.
Since there is insufficient evidence to recommend for or against prophylatic surgery for patients with congenital melanocytic nevi, physicians need to tailor management based on factors such as the size, thickness and locations of lesions for each patient, an expert says.
A proposed 10 percent tax on indoor tanning services is part of a revised Senate healthcare reform bill now headed to conference committee with a House bill.
The first U.S. face transplant recipient continues to regain sensory and motor capabilities, with future revision procedures planned.
Patients with treatment-resistant chronic idiopathic urticaria may respond more successfully to antihistamine therapy augmented with dapsone or colchicine.
Identifying precipitating events and treating patients with antidepressant Lexapro can help patients overcome delusions of parasitosis.